A Phase 2, Open-label, Translational Biology Study of Momelotinib in Transfusion-Dependent Subjects
Clinical Trial Grant
Awarded By
Gilead Sciences, Inc.
Start Date
April 17, 2016
End Date
June 27, 2019
Awarded By
Gilead Sciences, Inc.
Start Date
April 17, 2016
End Date
June 27, 2019